2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | DRUG RESISTANCE UPDATES DRUG RESIST UPDATE （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
57人评分
我要评分
声誉 10.0 影响力 8.6 速度 9.6 | |||||||||||||||||||||||||||||||||
| 期刊ISSN | 1368-7646 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||
| E-ISSN | 1532-2084 | |||||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 21.7 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：21.6 | |||||||||||||||||||||||||||||||||
| 2024-2025自引率 | 5.1%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
| 五年影响因子 | 23 | |||||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 3.88 | |||||||||||||||||||||||||||||||||
| h-index | 100 | |||||||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.journals.elsevier.com/drug-resistance-updates/ | |||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/dru/default.aspx | |||||||||||||||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/drug-resistance-updates/publish/guide-for-authors | |||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Interferon regulatory factor 5 associated neutrophil reprogramming by trained immunity protects against lethal-dose bacterial sepsis Author: Li, Liyuan; Liu, Chibo; Zhang, Mingming; Gou, Yawei; Zhang, Xinfang; Qi, Yan; Liu, Lingling; Wang, Renhao; Jiang, Jiashan; Wang, Ruonan; Wang, Shengnan; Shan, Wenbo; Zhao, Xi; Li, Haokun; Wang, Zhenbo; Li, Jing; Sun, Wei Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.drup.2026.101393 Nanoparticle-based immunotherapeutic strategies to overcome cancer drug resistance: From biological barriers to artificial intelligence-driven design Author: Kong, Xiangyi; Cheng, Ran; Zhang, Wenxiang; Lu, Ye; Kan, Yonemori; Fang, Yi; Gao, Jidong; Wang, Jing; Hwang, Kuo Chu Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101392 Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array-based cytokine profiling Author: Wickramasekara, Rochelle; Jones, Valerie; Zhao, Yating; Luo, Shuhong; Sun, Guogui; Huang, Ruo-Pan Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101378 Stabilin-1 +lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis Author: Wang, Qi; Zhou, Jiuli; Li, Xuefei; Zhao, Chao; Cheng, Lei; Wang, Li; Chen, Jianing; Chen, Chang; Li, Chunyu; Su, Chunxia Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101379 | |||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足DRUG RESISTANCE UPDATES的语言要求，还能让DRUG RESISTANCE UPDATES编辑和审稿人得到更好的审稿体验，让稿件最大限度地被DRUG RESISTANCE UPDATES编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes (Hybrid，可自选是否OA) | |||||||||||||||||||||||||||||||||
| 通讯方式 | CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF | |||||||||||||||||||||||||||||||||
| 出版商 | Churchill Livingstone | |||||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||||||||||
| 出版年份 | 1998 | |||||||||||||||||||||||||||||||||
| 年文章数 | 97点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 33.82% | |||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 100.00% | |||||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-7646%5BISSN%5D | |||||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 约稿?周期不定 | |||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||||||||||||||
| APC文章处理费信息 | 版面费：Article Publishing Charge (APC): USD 5,320 (excluding taxes). | |||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在DRUG RESISTANCE UPDATES顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Interferon regulatory factor 5 associated neutrophil reprogramming by trained immunity protects against lethal-dose bacterial sepsis Author: Li, Liyuan; Liu, Chibo; Zhang, Mingming; Gou, Yawei; Zhang, Xinfang; Qi, Yan; Liu, Lingling; Wang, Renhao; Jiang, Jiashan; Wang, Ruonan; Wang, Shengnan; Shan, Wenbo; Zhao, Xi; Li, Haokun; Wang, Zhenbo; Li, Jing; Sun, Wei Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.drup.2026.101393 PubMed DOI |
| 2. | Nanoparticle-based immunotherapeutic strategies to overcome cancer drug resistance: From biological barriers to artificial intelligence-driven design Author: Kong, Xiangyi; Cheng, Ran; Zhang, Wenxiang; Lu, Ye; Kan, Yonemori; Fang, Yi; Gao, Jidong; Wang, Jing; Hwang, Kuo Chu Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101392 PubMed DOI |
| 3. | Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array-based cytokine profiling Author: Wickramasekara, Rochelle; Jones, Valerie; Zhao, Yating; Luo, Shuhong; Sun, Guogui; Huang, Ruo-Pan Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101378 PubMed DOI |
| 4. | Stabilin-1 +lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis Author: Wang, Qi; Zhou, Jiuli; Li, Xuefei; Zhao, Chao; Cheng, Lei; Wang, Li; Chen, Jianing; Chen, Chang; Li, Chunyu; Su, Chunxia Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101379 PubMed DOI |
| 5. | Recent advances in near-infrared fluorescent ligands as a novel frontier in combating antibiotic-resistant bacteria Author: Zheng, Wen-De; Zeng, Yao-Xun; Chen, Ze-Xin; Dong, Jia-Peng; Zheng, Ying-Ying; Wong, Wing-Leung Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101382 PubMed DOI |
| 6. | ATP-binding cassette subfamily A member 5 suppresses pancreatic ductal adenocarcinoma progression and chemoresistance by promoting (3-catenin ubiquitin-dependent degradation Author: Li, Zhenchong; Ma, Zuyi; Chen, Yubin; Yu, Weixuan; Yu, Jiajie; Lu, Jianmin; Zhang, Qiaoling; Wu, Qianlong; Cai, Yifeng; Wang, Zeyao; Shang, Changzhen; Hou, Baohua; Zhang, Chuanzhao; Huang, Shanzhou; Wang, Linhe; Zhou, Qi Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101381 PubMed DOI |
| 7. | Emerging trends and converging evidence in tumor evolution: A comprehensive review Author: Jin, Chenqi; Li, Weiqi; Liu, Boqiang; Cao, Lu-Qi; Stefan, Sven Marcel; Yuan, Luoxi; Yu, Xin; Shi, Liang; Yu, Hong Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101380 PubMed DOI |
| 8. | Combination of PD-1 blockade and neoadjuvant chemoradiotherapy benefits pMMR/MSS patients with locally advance rectal cancer: A phase 2 clinical trial Author: Yang, Zhengyang; Xu, Zhuan; Sun, Liting; Zheng, Jianyong; Han, Jiagang; Li, Ang; Liu, Gang; Sun, Yi; Zhang, Jie; Chen, Guangyong; Xu, Rui; Zhang, Chao; Gao, Jiale; Bai, Zhigang; Deng, Wei; Yao, Hongwei; Zhang, Zhongtao Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101384 PubMed DOI |
| 9. | Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention Author: Guo, Dezhi; Guo, Yadong; Zhu, Chenglong; Liao, Yan; Lin, Zhiheng; Zhang, Haoling; Zhang, Wangzheqi; Zou, Zui Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101387 PubMed DOI |
| 10. | Oridonin derivative DLC13 targeting proliferating cell nuclear antigen to overcome oxaliplatin resistance in colorectal cancer☆ Author: Wang, Shuping; Li, Jipin; Chen, Yali; Gao, Tian; Yong, Tao; Zeng, Tingyu; An, Yu; Yang, Dong-Hua; Chen, Zhe-Sheng; Xu, Jinyi; Shi, Lei; Li, Dahong; Xu, Shengtao Journal: DRUG RESISTANCE UPDATES. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.drup.2026.101390 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共54条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
